Correlation of Point-of-Care ecarin clotting time versus activated clotting time with bivalirudin concentrations

This publication has 10 references indexed in Scilit:

• Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: Results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET)
  American Heart Journal, 2002
• Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Final report reanalysis of the Bivalirudin Angioplasty Study
  American Heart Journal, 2001
• Clinical Monitoring of Hirudin and Direct Thrombin Inhibitors
  Seminars in Thrombosis and Hemostasis, 2001
• Ecarin Clotting Time but not aPTT Correlates with PEG-Hirudin Plasma Activity
  Journal of Thrombosis and Thrombolysis, 2001
• Quantitative Determination of Hirudin in Blood and Body Fluids
  Seminars in Thrombosis and Hemostasis, 1996
• Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina
  New England Journal of Medicine, 1995
• Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty.
  Heart, 1990
• Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase
  Journal of the American College of Cardiology, 1988
• A Novel Whole Blood Capillary Technic for Measuring the Prothrombin Time
  American Journal of Clinical Pathology, 1987
• Evaluation of Tests Used to Monitor Heparin Therapy during Extracorporeal Circulation
  Anesthesiology, 1975